DAFNA Capital Management LLC — 13F Holdings

2026 Q3  ·  92 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, DAFNA Capital Management LLC maintained a portfolio of 92 distinct positions. The most significant new addition was BRIDGEBIO ONCOLOGY THERAPEUTIC, now representing 0.23% of the total fund value. They heavily accumulated shares in EUPRAXIA PHARMACEUTICALS INC, increasing the position by 79.3%. The fund also reduced its exposure to ISHARES NASDAQ BIOTECH INDX by 72.8%.
Position History hover any row below to update
Loading…
DAFNA Capital Management LLC Los Angeles, CA Hedge Fund / Asset Manager AUM $468M
PCA Score Concentration Risk
Risk ENB
Total Positions
92
Quarter
2026 Q3
Top Holding
RVMD (21.4%)
Top 10 Concentration
57.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 92

DAFNA Capital Management LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
RVMD
REVOLUTION MEDI...
Healthcare 21.36% 20.09% #1
Prev: #1
6.5
—
-75,500 -13.4%
P
S
487,130 $99,988,304 2020 Q4 13F Filing 2026-09-30 2026-11-16
ATRC
ATRICURE INC
Healthcare 6.28% 3.19% #2 6
Prev: #8
4.5
—
-74,684 -12.5%
P
S
522,747 $29,378,381 2012 Q2 13F Filing 2026-09-30 2026-11-16
CMPS
COMPASS PATHWAY...
Healthcare 5.68% 5.43% #3
Prev: #3
5.3
—
124,000 6.2%
P
S
2,135,952 $26,571,243 2022 Q1 13F Filing 2026-09-30 2026-11-16
XBI
SPDR S&P BIOTEC...
ETF 5.10% 5.93% #4 2
Prev: #2
2.5
—
-45,000 -22.9%
P
S
151,505 $23,889,308 2022 Q1 13F Filing 2026-09-30 2026-11-16
NKTR
NEKTAR THERAPEU...
Healthcare 4.18% 4.24% #5
Prev: #5
2.7
—
5,000 1.6%
P
S
323,380 $19,579,042 2009 Q4 13F Filing 2026-09-30 2026-11-16
IDYA
IDEAYA BIOSCIEN...
Healthcare 3.60% 3.53% #6 1
Prev: #7
1.9
—
-58,500 -11.8%
P
S
438,740 $16,856,391 2020 Q3 13F Filing 2026-09-30 2026-11-16
STXS
STEREOTAXIS INC
Healthcare 3.60% 4.49% #7 3
Prev: #4
2.4
—
no change no change
P
S
13,680,554 $16,827,081 2012 Q3 13F Filing 2026-09-30 2026-11-16
DNLI
DENALI THERAPEU...
Healthcare 3.29% 3.62% #8 2
Prev: #6
1.8
—
5,000 0.7%
P
S
744,014 $15,378,769 2025 Q1 13F Filing 2026-09-30 2026-11-16
ASND
ASCENDIS PHARMA...
Healthcare 2.43% 2.47% #9 3
Prev: #12
1.5
—
1,500 3.1%
P
S
49,969 $11,384,437 2015 Q1 13F Filing 2026-09-30 2026-11-16
RCUS
ARCUS BIOSCIENC...
Healthcare 2.43% 2.60% #10 1
Prev: #11
1.5
—
-2,000 -0.5%
P
S
439,829 $11,360,783 2018 Q1 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 2.42% 2.79% #11 1
Prev: #10
2.0
—
no change no change
P
S
171,998 $11,336,388 2015 Q4 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 1.92% 1.76% #12 4
Prev: #16
1.3
—
-5,000 -2.2%
P
S
221,819 $9,005,851 2022 Q1 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 1.90% 1.86% #13
Prev: #13
2.8
—
4,947 8.6%
P
S
62,716 $8,895,637 2008 Q3 13F Filing 2026-09-30 2026-11-16
PODD
INSULET CORP
Healthcare 1.89% 1.80% #14 1
Prev: #15
2.8
—
6,000 9.7%
P
S
67,870 $8,854,999 2008 Q4 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 1.63% 2.89% #15 6
Prev: #9
1.2
—
-46,000 -18.3%
P
S
204,772 $7,615,471 2015 Q3 13F Filing 2026-09-30 2026-11-16
AXGN
AXOGEN INC
Healthcare 1.61% 1.84% #16 2
Prev: #14
1.1
—
-29,000 -13.9%
P
S
179,960 $7,543,923 2021 Q4 13F Filing 2026-09-30 2026-11-16
DXCM
DEXCOM INC
Healthcare 1.59% 1.11% #17 6
Prev: #23
1.6
—
no change no change
P
S
86,279 $7,445,015 2012 Q1 13F Filing 2026-09-30 2026-11-16
SNDX
SYNDAX PHARMACE...
Healthcare 1.33% 1.40% #18 1
Prev: #19
1.0
—
-3,965 -1.2%
P
S
331,290 $6,228,252 2020 Q2 13F Filing 2026-09-30 2026-11-16
LRMR
LARIMAR THERAPE...
Healthcare 1.29% 1.17% #19 2
Prev: #21
1.0
—
-120,009 -6.0%
P
S
1,888,155 $6,032,655 2020 Q2 13F Filing 2026-09-30 2026-11-16
TNDM
TANDEM DIABETES...
Healthcare 1.24% 1.02% #20 6
Prev: #26
1.5
—
no change no change
P
S
355,208 $5,793,442 2015 Q1 13F Filing 2026-09-30 2026-11-16
BCAX
BICARA THERAPEU...
Healthcare 1.19% 1.61% #21 4
Prev: #17
2.5
—
15,000 5.3%
P
S
299,955 $5,582,163 2024 Q4 13F Filing 2026-09-30 2026-11-16
RAPP
RAPPORT THERAPE...
Healthcare 1.02% 0.60% #22 12
Prev: #34
3.4
—
66,900 89.2%
P
S
141,900 $4,767,840 2025 Q3 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
Healthcare 0.98% 1.10% #23 1
Prev: #24
0.9
—
-14,000 -9.4%
P
S
135,524 $4,578,001 2023 Q3 13F Filing 2026-09-30 2026-11-16
INGN
INOGEN INC
Healthcare 0.95% 1.04% #24 1
Prev: #25
1.4
—
no change no change
P
S
845,179 $4,454,093 2019 Q1 13F Filing 2026-09-30 2026-11-16
NGNE
NEUROGENE INC
Healthcare 0.89% 0.53% #25 12
Prev: #37
3.4
—
61,500 69.1%
P
S
150,532 $4,187,800 2024 Q2 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 0.88% 1.01% #26 1
Prev: #27
1.4
—
no change no change
P
S
101,266 $4,103,298 2024 Q2 13F Filing 2026-09-30 2026-11-16
IPSC
CENTURY THERAPE...
Healthcare 0.87% 1.12% #27 5
Prev: #22
0.8
—
-13,708 -0.6%
P
S
2,386,750 $4,081,343 2021 Q2 13F Filing 2026-09-30 2026-11-16
KIDS
ORTHOPEDIATRICS...
Healthcare 0.85% 0.69% #28 4
Prev: #32
0.8
—
-10,000 -5.3%
P
S
179,130 $3,989,225 2026 Q1 13F Filing 2026-09-30 2026-11-16
GLPG
LAKEFRONT BIOTH...
Healthcare 0.82% 0.74% #29 2
Prev: #31
1.3
—
no change no change
P
S
130,175 $3,859,689 2015 Q3 13F Filing 2026-09-30 2026-11-16
STOK
STOKE THERAPEUT...
Healthcare 0.81% 0.82% #30 2
Prev: #28
2.3
—
15,260 11.7%
P
S
146,135 $3,799,510 2024 Q1 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 0.80% 0.53% #31 7
Prev: #38
0.8
—
-6,790 -2.8%
P
S
232,763 $3,724,208 2026 Q2 13F Filing 2026-09-30 2026-11-16
EPRX
EUPRAXIA PHARMA...
Healthcare 0.79% 0.28% #32 23
Prev: #55
3.3
—
178,967 79.3%
P
S
404,567 $3,681,560 2026 Q2 13F Filing 2026-09-30 2026-11-16
CLDX
CELLDEX THERAPE...
Healthcare 0.75% 0.49% #33 8
Prev: #41
3.3
—
39,600 57.8%
P
S
108,118 $3,504,104 2025 Q3 13F Filing 2026-09-30 2026-11-16
ALLO
ALLOGENE THERAP...
Healthcare 0.68% 0.79% #34 5
Prev: #29
1.3
—
no change no change
P
S
2,000,000 $3,200,000 2024 Q2 13F Filing 2026-09-30 2026-11-16
BCRX
BIOCRYST PHARMA...
Healthcare 0.68% 0.76% #35 5
Prev: #30
0.8
—
-20,000 -5.0%
P
S
380,248 $3,167,466 2014 Q3 13F Filing 2026-09-30 2026-11-16
KYMR
KYMERA THERAPEU...
Healthcare 0.64% 0.59% #36 1
Prev: #35
0.8
—
-88 -0.3%
P
S
26,912 $3,008,492 2026 Q2 13F Filing 2026-09-30 2026-11-16
AQST
AQUESTIVE THERA...
Healthcare 0.63% 0.51% #37 3
Prev: #40
0.8
—
-5,000 -0.8%
P
S
640,915 $2,967,436 2024 Q1 13F Filing 2026-09-30 2026-11-16
N/A
ATRIUM THERAPEU...
Unknown 0.53% 0.33% #38 13
Prev: #51
3.2
—
172,076 134.4%
P
S
300,076 $2,484,629 — 13F Filing 2026-09-30 2026-11-16
IBB
ISHARES NASDAQ ...
ETF 0.52% 1.54% #39 21
Prev: #18
0.2
—
-31,000 -72.8%
P
S
11,595 $2,441,095 2006 Q4 13F Filing 2026-09-30 2026-11-16
PRCT
PROCEPT BIOROBO...
Healthcare 0.47% 0.52% #40 1
Prev: #39
1.2
—
no change no change
P
S
120,000 $2,186,400 2023 Q2 13F Filing 2026-09-30 2026-11-16
PRQR
PROQR THERAPEUT...
Healthcare 0.47% 0.54% #41 5
Prev: #36
0.7
—
-217,831 -14.2%
P
S
1,312,530 $2,178,800 2017 Q4 13F Filing 2026-09-30 2026-11-16
CYBN
CYBIN INC
Unknown 0.46% 0.65% #42 9
Prev: #33
0.2
—
-338,359 -65.8%
P
S
175,702 $2,159,378 2025 Q4 13F Filing 2026-09-30 2026-11-16
ALGN
ALIGN TECHNOLOG...
Healthcare 0.43% 0.45% #43
Prev: #43
1.2
—
no change no change
P
S
14,000 $2,034,900 2024 Q4 13F Filing 2026-09-30 2026-11-16
VKTX
VIKING THERAPEU...
Healthcare 0.38% 0.44% #44
Prev: #44
0.7
—
-5,000 -8.4%
P
S
54,516 $1,777,222 2018 Q4 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 0.38% 0.37% #45 2
Prev: #47
1.2
—
no change no change
P
S
65,000 $1,766,700 2026 Q1 13F Filing 2026-09-30 2026-11-16
ALEC
ALECTOR INC
Healthcare 0.36% 0.35% #46 2
Prev: #48
1.1
—
no change no change
P
S
908,351 $1,680,449 2019 Q1 13F Filing 2026-09-30 2026-11-16
TELA
TELA BIO INC
Healthcare 0.35% 0.21% #47 16
Prev: #63
1.1
—
no change no change
P
S
1,441,029 $1,657,183 2024 Q4 13F Filing 2026-09-30 2026-11-16
MPLT
MAPLIGHT THERAP...
Healthcare 0.34% 1.17% #48 28
Prev: #20
0.6
—
-15,427 -9.0%
P
S
155,579 $1,585,350 2025 Q4 13F Filing 2026-09-30 2026-11-16
NGENF
NERVGEN PHARMA ...
Unknown 0.33% 0.41% #49 4
Prev: #45
0.1
—
-239,138 -22.8%
P
S
810,862 $1,548,746 2026 Q2 13F Filing 2026-09-30 2026-11-16
GPCR
STRUCTURE THERA...
Healthcare 0.31% 0.48% #50 8
Prev: #42
1.1
—
no change no change
P
S
46,500 $1,454,055 2024 Q2 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 92 holdings

Unlock Full DAFNA Capital Management LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →